Cardiology
The Society for Cardiac Angiography and Interventions American Heart Association  Heart Online    Association of British Medical Journals   TCTMD
Cardiology » Articles » Quantitative Three-dimensional Echocardiography in Congenital Heart Disease
Saturday, 17 May, 2008



Quantitative Three-dimensional Echocardiography in Congenital Heart Disease

G Hamilton Baker Medical University of South Carolina Children’s Hospital , Girish S Shirali Medical University of South Carolina Children’s Hospital

  Previous    1    2     Next  

Congenital heart disease affects approximately 0.8% of the population.1 It is also estimated that there are approximately one million adults in the US living with some form of congenital heart disease.2 In daily practice, echocardiography is the most widely used imaging modality for diagnosis and evaluation of these patients. As medical technology has developed, this modality has continuously evolved to provide better qualitative and quantitative assessment of cardiac anatomy and function.

One of the more recent developments in echocardiography is realtime threedimensional echocardiography (3-DE). Recent technological advances, including the matrix array transducer and increased computer processing speed, have transformed 3-DE from a complex, time-consuming process into a practical bedside tool. 3-DE now provides the echocardiographer with a virtual window into the three-dimensional complexity of congenital heart disease. Using this unique and powerful tool, normal and pathological entities can be analyzed in completely new ways. One of the more important contributions of 3-DE is the ability to accurately and directly assess entire cardiac chambers. Using 3-DE, one can dynamically evaluate global and segmental left ventricular volume at the patient’s bedside, which has led to significant advances in our ability to objectively quantify left ventricular function.

Quantitative 3-DE—Acquiring the Data Set

Quantitative assessment of ventricular function plays a vital role in the management of patients with congenital heart disease. This has traditionally been accomplished with two-dimensional (2-D) echocardiography; however, 2-D quantitative methods are limited by their dependence on geometric assumptions of ventricular shape. 3-DE achieves freedom from geometric assumptions with 3-D volumetric data in the form of voxels. Voxels are the 3-D correlate of a 2-D pixel, and offer a more robust representation of ventricular volume. Earlier approaches to 3-D reconstruction interpolated 2-D pixel data to build 3-D images. In contrast, with 3-D voxels, there is no need for reconstructions or assumptions. In order to capture entire cardiac structures and chambers, full volume 3-DE (FV-3-DE) is used. FV-3-DE is a technology that rapidly acquires large pyramidal sections of 3-D data called FV-data sets. These FV-data sets are acquired as separate pieces over four to seven consecutive cardiac cycles. The information from each cycle is matched with the other cardiac cycles through ECG gating; the data sets are stitched together to create a single large pyramid-shaped wedge of 3-D data. Once acquired, these FVdata sets can be analyzed immediately at the bedside or stored for later analysis. With this technology, we now have the ability to rapidly acquire the left ventricle, through the entire cardiac cycle, in a single FV-data set. A wide variety of analyses can be performed on the FV-data sets with various software tools. These range from virtual dissection using cut-plane cropping, to complex quantitative analysis of myocardial wall deformation and dyssynchrony.

3-D Global and Segmental Ventricular Analysis

One important and useful analysis that can be performed on FV-data sets is left ventricular volume analysis (LVVA). There are multiple software platforms available for LVVA. Most of these involve the echocardiographer aligning the data set along its axes and then marking a series of anatomical landmarks. This process allows a semi-automated border detection algorithm to trace the LV endocardium throughout the cardiac cycle and create a dynamic cast of the LV chamber. Numerous studies have validated the diagnostic potential of 3-D LVVA and its superior accuracy to 2-D methods in adults and children.3,4 While LVVA has the potential to become part of the routine echocardiogram, the integration of any new technology into mainstream clinical medicine is, in large part, dependent on its reproducibility in the clinical setting and the resource utilization it requires. The authors, in their echocardiography lab, recently performed a study to evaluate the time resource utilization of this new modality using a commercially available software application in patients with congenital heart disease. This demonstrated that global LVVA could be completed in approximately two to three minutes by users with varying experience levels in a highly reproducible manner.5

In addition to global LVVA, a more sophisticated segmental analysis can be performed by dividing the left ventricle into 16 segments (American Society of Echocardiography model).6 The volume of each ventricular segment can be graphed separately as a function of time throughout the cardiac cycle (see Figure 1). Segmental ejection fractions can be calculated and compared, and regional differences in myocardial wall deformation can be illustrated. In addition, one can use the dispersion of volume change over time to evaluate dyssynchrony.

  Previous    1    2     Next  

Keywords and Categories

Author(s) Biography
G Hamilton Baker, MD, is a Fellow in the Division of Pediatric Cardiology at the Medical University of South Carolina Children’s Hospital. He is currently performing advanced training in both pediatric interventional cardiology and echocardiography. His specific research and career interests are quantitative threedimensional echocardiography and three-dimensional echocardiographic guidance of interventional cardiac procedures. E: baker@musc.edu
Girish S Shirali, MBBS, FACC, FAAP, is a Professor in the Departments of Pediatrics and Obstetrics/Gynecology, a Director of Pediatric Echocardiography, and a Director of Fellowship Training at the Medical University of South Carolina, Charleston, South Carolina.

Send Article Feedback
Title*:

Comment*:

Name*:
Email Address*:
Location*:

Add me to mailing list

I Agree to terms and conditions


Order Reprint


Order high-quality repints of any
articles on this website


Instructions for Authors
Instructions for authors, click here for details

Submit an Article
Submit an article, click here for details

  Copyright Touch Briefings 2005 - 2008    Promotional Opportunities | Terms & Conditions | Privacy Statement|

Articles : a b c d e f g h i j k l m n o p q r s t u v w x y z
Companies : a b c d e f g h i j k l m n o p q r s t u v w x y z
Events : a b c d e f g h i j k l m n o p q r s t u v w x y z
Keywords : a b c d e f g h i j k l m n o p q r s t u v w x y z

Specialities :

Arrhythmia Cardiac Imaging Congenital Heart Disease Coronary Artery Disease Heart Disease Prevention Heart Failure Hyperlipidemia Hypertension Interventional Cardiology Pediatric Cardiology Peripheral Artery Disease

Other Touch Group sites:   

Neurology - Endocrine Disease - Oncological Disease - Gastroenterology - Respiratory Disease